Is Selenium Metabolism Necessary for Its Anticarcinogenic Activity?

Conference paper

Abstract

At the Third International Selenium Symposium held in Beijing in 1984, I presented a talk entitled, “Susceptibility of Mammary Carcinogenesis in Response to Dietary Selenium Levels” (Ip 1987). Since the current lecture is going to discuss new developments from our laboratory in the past few years, including both published and unpublished data, a brief review and update of the Beijing presentation would be relevant to serve as background materials.

Keywords

Glutathione Selenium Methionine Anthracene GSSG 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bertram JS, Kolonel LN, Meyskens FL Jr (1987) Rationale and strategies for chemoprevention of cancer in humans. Cancer Res 47: 3012–3031PubMedGoogle Scholar
  2. Foster SJ, Kraus RJ, Ganther HE (1986) Formation of dimethyl selenide and trimethylselenonium from selenobetaine in the rat. Arch Biochem Biophys 247: 12–19PubMedCrossRefGoogle Scholar
  3. Ganther He, Levander OA, Baumann CA (1966) Dietary control of selenium volatilization in the rat. J Nutr 88: 55–60PubMedGoogle Scholar
  4. Hill CH (1975) Interrelationships of selenium with other trace elements. Fed Proc 34: 2096–2100PubMedGoogle Scholar
  5. Horvath PM, Ip C (1983) Synergistic effect of vitamin E and selenium in the chemoprevention of mammary carcinogenesis in rats. Cancer Res 43: 5335–5341Google Scholar
  6. Hsieh HS, Ganther HE (1977) Biosynthesis of dimethyl selenide from sodium selenite in rat liver and kidney cell-free systems. Biochim Biophys Acta 497: 205–217PubMedGoogle Scholar
  7. Ip C (1981a) Factors influencing the anticarcinogenic efficacy of selenium in dimethylbenz(a)-anthracene-induced mammary tumorigenesis in rats. Cancer Res 41:2683–2686Google Scholar
  8. Ip C (1981b) Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical carcinogenesis. Cancer Res 41:4386–4390Google Scholar
  9. Ip C (1985) Attenuation of the anticarcinogenic action of selenium by vitamin E deficiency. Cancer Lett 25: 325–331PubMedGoogle Scholar
  10. Ip C (1986) The chemopreventive role of selenium in carcinogenesis. J Am Coll Toxicol 5: 7–20CrossRefGoogle Scholar
  11. Ip C (1987) Susceptibility of mammary carcinogenesis in response to dietary selenium levels: modification by fat and vitamin intake. In: Combs GF Jr, Spallholz JE, Levander OA, Oldfield JE (eds) Selenium in biology and medicine. 3rd Int Symp, part B. Van Nostrand Reinhold, New York, pp 1009–1022Google Scholar
  12. Ip C (1988a) Feasibility of using lower doses of chemopreventive agenst in a combination regimen for cancer protection. Cancer Lett 39: 239–246CrossRefGoogle Scholar
  13. Ip C (1988b) Differential effect of dietary methionine on the biopotency of selenomethionine and selenite in cancer chemoprevention. J Natl Cancer Inst 80: 258–262CrossRefGoogle Scholar
  14. Ip C, Daniel FB (1985) Effects of selenium on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis and DNA adduct formation. Cancer Res 45: 61–65PubMedGoogle Scholar
  15. Ip C, Ganther H (1988) Efficacy of trimethylselenonium versus selenite in cancer chemoprevention and its modulation by arsenite. Carcinogenesis 9: 1481–1484PubMedCrossRefGoogle Scholar
  16. Ip C, Medina D (1987) Current concept of selenium and mammary tumorigenesis. In: Medina D, Kidwell W, Heppner, G, Anderson EP (eds) Cellular and molecular biology of breast cancer. Plenum, New York London, pp 479–494CrossRefGoogle Scholar
  17. Ip C, Sinha DK (1981) Enhancement of mammary tumorigenesis by dietary selenium deficiency in rats with a high polyunsaturated fat intake. Cancer Res 41: 31–34PubMedGoogle Scholar
  18. Ip C, White G (1987) Mammary cancer chemoprevention by inorganic and organic selenium: single agent treatment or in combination with vitamin E and their effects on in vitro immune functions. Carcinogenesis 8: 1763–1766Google Scholar
  19. LeBoeuf RA, Hoekstra WG (1983) Adaptive changes in hepatic glutathione metabolism in response to excess selenium in rats. J Nutr 113: 845–854PubMedGoogle Scholar
  20. LeBoeuf RA, Hoekstra WG (1985) Changes in cellular glutathione levels: possible relation to selenium-mediated anticarcinogenesis. Fed Proc 44: 2563–2567PubMedGoogle Scholar
  21. Morrison DG, Medina D (1988) Intracellular 58K selenoprotein levels correlate with inhibition of DNA synthesis in MMEC lines. Proc Am Assoc Cancer Res 29: 19 (Abstr No 74)Google Scholar
  22. Morrison DG, Berdan RC, Pauly DF, Turner DS, Oborn CJ, Medina D (1988) Selenium distribution in mammary epithelial cells reveals its possible mechanism of inhibition of cell growth. Anticancer Res 8: 51–64PubMedGoogle Scholar
  23. Obermeyer BD, Palmer IS, Olson 0E, Halverson AW (1971) Toxicity of trimethylselenonium chloride in the rat with and without arsenite. Toxicol Appl Pharmacol 20: 135–146Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • C. Ip
    • 1
  1. 1.Department of Breast SurgeryRoswell Park Memorial InstituteBuffaloUSA

Personalised recommendations